Based on this case, for younger patients without obvious high-risk factors for pulmonary embolism, it is recommended to conduct initial phenotypic testing for hereditary thrombophilia, such as AT III, PS, and PC activity. This evidence concerns the gene SERPINC1 and Rare hereditary thrombophilia.